JXL082

JXL082, or JXL-082, is a drug acting as a mitochondrial pyruvate carrier (MPC) inhibitor which was synthesized towards the aim of developing a treatment for hair loss.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

JXL082, or JXL-082, is a drug acting as a mitochondrial pyruvate carrier (MPC) inhibitor which was synthesized towards the aim of developing a treatment for hair loss. It is related to other drugs in the same series such as suvomipic (PP405; JXL069) and UK-5099 (JXL001). The drug is known to have been sold online in a grey market fashion for treatment of hair loss.

It has been mistakenly believed to be suvomipic in the past. JXL082 was first described in the scientific literature by 2019.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1368521906 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

2 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.